Incidence of stress fractures of the femoral shaft in women treated with bisphosphonate
Open Access
- 1 January 2009
- journal article
- research article
- Published by Medical Journals Sweden AB in Acta Orthopaedica
- Vol. 80 (4), 413-415
- https://doi.org/10.3109/17453670903139914
Abstract
Background Recent case reports have identified an association between long-term bisphosphonate treatment and stress fractures of the femoral shaft. The risk of such fractures in bisphosphonate users has not been determined. Methods We identified women over 55 years of age with the specific fracture pattern by searching the operation registry of the hospitals in 2 healthcare districts. Prevalence of bisphosphonate treatment was provided by a Swedish national registry covering all drugs delivered to all individuals since 2005. Results The number of women on bisphosphonate treatment was 3,087. Of these, 5 had femoral stress fractures. They had been taking bisphosphonates for 3.5 to 8.5 years. The incidence density for a patient on bisphosphonate was 1/1,000 per year (95% CI: 0.3–2). In the remaining 88,869 women who were not taking bisphosphonates, there were 3 stress fractures. Thus, their risk (without correction for inhomogeneity in age distribution) was 46 times less (95% CI: 11–200). Interpretation These results are rough estimations based on a comparatively small material. Still, a treatment-associated incidence density of 1/1,000 is acceptable, considering that bisphosphonate treatment is likely to reduce the incidence density of any fracture by 15/1,000 according to a large randomized trial ().This publication has 8 references indexed in Scilit:
- More on Atypical Fractures of the Femoral DiaphysisThe New England Journal of Medicine, 2008
- Low-Energy Femoral Shaft Fractures Associated With Alendronate UseJournal of Orthopaedic Trauma, 2008
- Atypical Fractures of the Femoral Diaphysis in Postmenopausal Women Taking AlendronateThe New England Journal of Medicine, 2008
- An emerging pattern of subtrochanteric stress fractures: A long-term complication of alendronate therapy?Injury, 2008
- Subtrochanteric displaced insufficiency fracture after long‐term alendronate therapy—a case reportActa Orthopaedica, 2008
- Subtrochanteric insufficiency fractures in patients on alendronate therapyThe Journal of Bone and Joint Surgery. British volume, 2007
- Effects of Continuing or Stopping Alendronate After 5 Years of TreatmentJama-Journal Of The American Medical Association, 2006
- Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fracturesThe Lancet, 1996